Inogen (INGN) Stock Analysis & Winston Score

Inogen makes portable oxygen concentrators — small, battery-powered devices that help people with lung diseases breathe more easily at home or on the go. Its main customers are patients with conditions like COPD who need supplemental oxygen, sold through home healthcare providers, direct-to-consumer channels, and international distributors. The company competes in the medical device industry and is known for pioneering lightweight, portable alternatives to heavy oxygen tanks. Inogen earns revenue by selling its concentrator devices outright and, to a smaller extent, through rental arrangements and accessories. It operates primarily in the United States but also sells internationally across Europe and other markets. The company's brand recognition and product design give it some competitive standing, but it faces pressure from larger medical equipment companies and ongoing pricing competition. Its biggest challenge is returning to profitability — operating margins are currently negative, and the company must grow sales volume while controlling costs to reach sustainable earnings.